NO20052975L - Nye 2',5'-oligoadenylsyreanaloger. - Google Patents
Nye 2',5'-oligoadenylsyreanaloger.Info
- Publication number
- NO20052975L NO20052975L NO20052975A NO20052975A NO20052975L NO 20052975 L NO20052975 L NO 20052975L NO 20052975 A NO20052975 A NO 20052975A NO 20052975 A NO20052975 A NO 20052975A NO 20052975 L NO20052975 L NO 20052975L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- mercapto
- nucleic acid
- synthesis
- blocked
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 230000015572 biosynthetic process Effects 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 125000006239 protecting group Chemical group 0.000 abstract 3
- 238000003786 synthesis reaction Methods 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- -1 mercapto, mercapto Chemical class 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/319—Chemical structure of the backbone linked by 2'-5' linkages, i.e. having a free 3'-position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3515—Lipophilic moiety, e.g. cholesterol
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002334731 | 2002-11-19 | ||
| PCT/JP2003/014748 WO2004046161A1 (fr) | 2002-11-19 | 2003-11-19 | Nouveaux analogues d'acide 2',5'-oligoadenylique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052975D0 NO20052975D0 (no) | 2005-06-17 |
| NO20052975L true NO20052975L (no) | 2005-08-18 |
Family
ID=32321740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052975A NO20052975L (no) | 2002-11-19 | 2005-06-17 | Nye 2',5'-oligoadenylsyreanaloger. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7651999B2 (fr) |
| EP (1) | EP1568704A4 (fr) |
| KR (1) | KR101117998B1 (fr) |
| CN (1) | CN1738829B (fr) |
| AU (1) | AU2003284578B2 (fr) |
| BR (1) | BR0316431A (fr) |
| CA (1) | CA2506581C (fr) |
| CO (1) | CO5690648A2 (fr) |
| IL (1) | IL168475A (fr) |
| MX (1) | MXPA05005321A (fr) |
| NO (1) | NO20052975L (fr) |
| NZ (1) | NZ539979A (fr) |
| PL (1) | PL211566B1 (fr) |
| RU (1) | RU2311422C2 (fr) |
| TW (1) | TWI347948B (fr) |
| WO (1) | WO2004046161A1 (fr) |
| ZA (1) | ZA200504017B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179796B2 (en) | 2000-01-18 | 2007-02-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of PTP1B expression |
| US20020055479A1 (en) | 2000-01-18 | 2002-05-09 | Cowsert Lex M. | Antisense modulation of PTP1B expression |
| TWI347948B (en) * | 2002-11-19 | 2011-09-01 | Sankyo Co | Novel 2',5'-oligoadenylic acid compositions |
| US20050106101A1 (en) * | 2003-10-31 | 2005-05-19 | Ajay Purohit | Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use |
| EP2275457B1 (fr) * | 2005-05-18 | 2016-11-23 | Mitsui Chemicals, Inc. | Composition polymère à base de propylène et produits moulés, feuilles, films, laminés et textiles non-tissés à base de ladite composition |
| CA2676822A1 (fr) * | 2007-01-31 | 2008-08-07 | Alios Biopharma, Inc. | Analogues de 2-5a et leurs procedes d'utilisation |
| WO2009086201A1 (fr) * | 2007-12-21 | 2009-07-09 | Alios Biopharma, Inc. | Analogues 2-5a et leur utilisation en tant qu'agents anticancéreux, antiviraux et antiparasitaires |
| US20100009451A1 (en) * | 2008-05-30 | 2010-01-14 | Sigma Aldrich Company | Compositions and methods for specifically silencing a target nucleic acid |
| CN103547588B (zh) | 2011-04-13 | 2016-06-29 | Isis制药公司 | Ptp1b表达的反义调节 |
| EP2862868B1 (fr) * | 2012-06-18 | 2020-04-08 | Daiichi Sankyo Company, Limited | Intermédiaire pour la production d'un analogue de nucléoside, et son procédé de production |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68929321T2 (de) * | 1988-06-09 | 2002-05-08 | Temple University Of The Commonwealth System Of Higher Education, Philadelphia | Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten |
| RU2131436C1 (ru) * | 1990-09-13 | 1999-06-10 | Санофи | Резистентные к нуклеазе олигонуклеозиды, способ их получения и резистентный к нуклеазе нуклеозидный димер |
| JP3781879B2 (ja) | 1996-11-18 | 2006-05-31 | 武 今西 | 新規ヌクレオチド類縁体 |
| JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| ES2234563T5 (es) * | 1999-02-12 | 2018-01-17 | Daiichi Sankyo Company, Limited | Nuevos análogos de nucleósidos y oligonucleótidos |
| JP2003510281A (ja) * | 1999-09-29 | 2003-03-18 | ザ クリーブランド クリニック ファウンデーション | ２−５ａおよびインターフェロンを用いる治療 |
| JP4245837B2 (ja) * | 2000-12-21 | 2009-04-02 | 第一三共株式会社 | ２’，５’−オリゴアデニル酸類縁体 |
| TWI347948B (en) * | 2002-11-19 | 2011-09-01 | Sankyo Co | Novel 2',5'-oligoadenylic acid compositions |
-
2003
- 2003-11-18 TW TW092132261A patent/TWI347948B/zh not_active IP Right Cessation
- 2003-11-19 CN CN2003801089629A patent/CN1738829B/zh not_active Expired - Fee Related
- 2003-11-19 NZ NZ539979A patent/NZ539979A/en not_active IP Right Cessation
- 2003-11-19 WO PCT/JP2003/014748 patent/WO2004046161A1/fr not_active Ceased
- 2003-11-19 KR KR1020057009011A patent/KR101117998B1/ko not_active Expired - Fee Related
- 2003-11-19 BR BR0316431-4A patent/BR0316431A/pt not_active IP Right Cessation
- 2003-11-19 MX MXPA05005321A patent/MXPA05005321A/es active IP Right Grant
- 2003-11-19 CA CA2506581A patent/CA2506581C/fr not_active Expired - Fee Related
- 2003-11-19 EP EP03774061A patent/EP1568704A4/fr not_active Withdrawn
- 2003-11-19 RU RU2005115129/04A patent/RU2311422C2/ru not_active IP Right Cessation
- 2003-11-19 PL PL376926A patent/PL211566B1/pl not_active IP Right Cessation
- 2003-11-19 AU AU2003284578A patent/AU2003284578B2/en not_active Ceased
-
2005
- 2005-05-09 IL IL168475A patent/IL168475A/en not_active IP Right Cessation
- 2005-05-16 US US11/131,412 patent/US7651999B2/en not_active Expired - Fee Related
- 2005-05-18 ZA ZA200504017A patent/ZA200504017B/en unknown
- 2005-05-18 CO CO05048112A patent/CO5690648A2/es unknown
- 2005-06-17 NO NO20052975A patent/NO20052975L/no not_active Application Discontinuation
-
2009
- 2009-10-09 US US12/587,608 patent/US7994152B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CO5690648A2 (es) | 2006-10-31 |
| BR0316431A (pt) | 2005-10-11 |
| US7651999B2 (en) | 2010-01-26 |
| EP1568704A4 (fr) | 2009-12-02 |
| PL211566B1 (pl) | 2012-05-31 |
| TW200416224A (en) | 2004-09-01 |
| WO2004046161A1 (fr) | 2004-06-03 |
| TWI347948B (en) | 2011-09-01 |
| KR101117998B1 (ko) | 2012-04-12 |
| US20050261235A1 (en) | 2005-11-24 |
| US7994152B2 (en) | 2011-08-09 |
| RU2005115129A (ru) | 2006-02-27 |
| MXPA05005321A (es) | 2005-07-25 |
| ZA200504017B (en) | 2006-02-22 |
| NO20052975D0 (no) | 2005-06-17 |
| AU2003284578A1 (en) | 2004-06-15 |
| AU2003284578B2 (en) | 2007-07-05 |
| CA2506581A1 (fr) | 2004-06-03 |
| CN1738829A (zh) | 2006-02-22 |
| CN1738829B (zh) | 2012-11-28 |
| CA2506581C (fr) | 2013-05-28 |
| NZ539979A (en) | 2007-05-31 |
| IL168475A (en) | 2010-05-31 |
| US20100035976A1 (en) | 2010-02-11 |
| RU2311422C2 (ru) | 2007-11-27 |
| EP1568704A1 (fr) | 2005-08-31 |
| PL376926A1 (pl) | 2006-01-09 |
| KR20050083891A (ko) | 2005-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ513402A (en) | Novel nucleosides and oligonucleotide analogues | |
| NO20052975L (no) | Nye 2',5'-oligoadenylsyreanaloger. | |
| WO2007118198A8 (fr) | ANALOGUES DE LA 2-MÉTHYLÈNE-1α,25-DIHYDROXY-19,21-DINOR-VITAMINE D3 ET LEURS UTILISATIONS | |
| HUP0101137A2 (hu) | Véralvadást gátló savamidin-származékok és gyógyászati alkalmazásuk | |
| CL2004000917A1 (es) | Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa | |
| HUP0400206A2 (hu) | Metalloproteináz inhibitor hatású imidazolidin-dion-származékok, ezek alkalmazása gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények | |
| ECSP045229A (es) | Piridinonas sustituidas como moduladores de la p38 map quinasa | |
| UA85583C2 (ru) | Применение ротиготина для профилактики и лечения синдрома паркинсона (плюс) | |
| ATE277066T1 (de) | Bicyclonucleosid-analoga | |
| UA84460C2 (ru) | Применение сульфонилкарбамидов для борьбы с нежелательным ростом растений в культурах бобовых | |
| BRPI0111222B8 (pt) | derivados fosfonados de glicopeptídeo. | |
| TR200202200T2 (tr) | Glükopiranosiloksibenzilbenzen türevleri, bu türevleri ihtiva eden tıbbi bileşimler ve türevlerin hazırlanması için ara-maddeler. | |
| BRPI0413353A (pt) | composição farmacêutica contendo droga solúvel em água | |
| BRPI0508047A (pt) | derivados de alquilpiperazina-e alquil-homopiperazina-carboxilatos, o respectivo preparo e a respectiva aplicação como inibidores da enzima faah | |
| EA029775B9 (ru) | Применение 1,3,5-триазин-2-ил фосфорамидатного соединения в синтезе софосбувира | |
| ATE554753T1 (de) | 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia | |
| EA200701406A1 (ru) | Приемлемые для лечения вич соединения | |
| BR0307033A (pt) | ácidos 3-(imidazolil)-2-aminopropanóicos para o uso como inibidores tafi-a para o tratamento de doenças trombóticas | |
| HUP0000572A2 (hu) | Nukleotid analógot tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| BRPI0409798A (pt) | geração de plantas com teor alterado de óleo | |
| BR9912817A (pt) | Composição terapêutica à base de isoflavonóides destinada a ser utilizada no tratamento dos tumores por agentes citotóxicos | |
| DK1135401T3 (da) | Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelse | |
| TW200724131A (en) | Antibacterial 5,5'-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy-1,1'-biphenyl compounds and related methods | |
| DK1848442T3 (da) | 2-methylene-19-nor-(20s-24epi)-1alfa,25-dihydroxyvitamine-d2 | |
| ATE525386T1 (de) | 3'-ethynylcytidinderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |